Xlear Inc. centers on proactive health—staying healthy through transformational hygiene. Xlear xylitol-based products support that goal.
This pandemic could have subsided months ago if our public health officials had listened to the physicians and scientists working on the front lines. Sadly, most officials have donned blinders, only focused on Operation Warp Speed and vaccination development—vaccines that many people will refuse to or cannot take.
Last March would have been a great time for public health officials to consider using antiviral nasal sprays. Another great time is now. However, most health officials are too afraid or close-minded. Like the physicians who ridiculed the first researcher and promoter of handwashing in 1848, our public health officials mock what they view as too simplistic.
Below are synopses of studies which show why you need to add nasal sprays to your prevention protocol against COVID-19.
Anti-Adherence of Bacteria – 1998
This study found that xylitol blocked adhesion of bacteria to epithelial cells, showing that xylitol inhibits bacteria from sticking to tissue, which allows the body to wash them away.
Kontiokari, T., Uhari, M., & Koskela, M. (1998). Antiadhesive effects of xylitol on otopathogenic bacteria. The Journal of Antimicrobial Chemotherapy, 41(5), 563–565.
Airway Study – 2015
In a 2015 presentation, Dr. Nsouli shared his findings of a study which showed that a nasal spray with xylitol increased peak airflow 36% more than saline alone and measurably increased participants’ quality of life.
Nsouli, T. M.; et al., (2015) ORAL ABSTRACT #46.
Improved Nasal Volume Utilizing Hyperosmotic Saline Xylitol Mixture (Effective Alternative or Adjunct to Decongestants and Antihistamines) – 2019
In this article Drs. Olmos and Baba discuss their findings which showed that 3 minutes after spraying participants’ noses with a saline and xylitol spray, they experienced a 20% improvement in airway volume.
Olmos, S., Baba, J., (2019.). Improved Nasal Volume Utilizing Hyperosmotic Saline Xylitol Mixture (Effective Alternative or Adjunct to Decongestants and Antihistamines). EC Pulmonology and Respiratory Medicine 8.5, 444-452.
High Viral Load in the Nose – Mar. 2020
In this correspondence, researchers shared their research which showed that the nose has the highest viral load of SARS-CoV-2 than elsewhere in the body when infected with the virus.
Zou, L., et al., (2020). SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. The New England Journal of Medicine, 382(12), 1177–1179.
Mapping How SARS-CoV-2 Infects the Body – May, 2020
In this study done at UNC Chapel Hill, researchers found that the SARS-CoV-2 virus first infects the body through the nose, establishes itself there, and then progresses into the airway and lungs.
Hou, Y. J., et al., (2020). SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract. Cell, 182(2), 429-446.e14.
The Three Stages of SARS-CoV-2 Infection – Jul. 2020
The paper’s authors show that like other illnesses which affect the lungs, the SARS-CoV-2 virus has three stages of infection, and if left unchecked, it could cause irreversible damage to lungs. They argue medical professionals must give greater attention and treatment in the earlier stages of infection.
Sanchez-Gonzalez, M. A., et al., (2020). A Pathophysiological Perspective on COVID-19’s Lethal Complication: From Viremia to Hypersensitivity Pneumonitis-like Immune Dysregulation. Infection & Chemotherapy, 52(3), 335–344.
Benefits and Safety of Nasal Saline Irrigations in a Pandemic—Washing SARS-CoV-2 Away – Jul. 2020
In this paper, researchers discuss how cleaning the sinuses with a simple saline could be useful during the pandemic. They conclude saying that adding an anti-viral or virucidal agents to the saline could be beneficial against SARS-CoV-2.
Farrell NF, et al. (2020). Benefits and Safety of Nasal Saline Irrigations in a Pandemic—Washing COVID-19 Away. JAMA Otolaryngol Head Neck Surg., 146(9):787–788.
Anti-Adherence of SARS-CoV-2 Virus – Aug. 2020
In a study looking at Iota-carrageenan’s effect on SARS-CoV-2, researchers found that xylitol also had an anti-adherence effect on the virus.
Vega, J. C., et al., (2020). Iota carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture. BioRxiv.
Using Nasal Sprays to Combat SARS-CoV-2 – Sept. 2020
Researchers concluded that using a nasal spray that deactivates the SARS-CoV-2 virus in the nose, “may not only prevent person-to-person spread of SARS-CoV-2, but may also diminish the severity of disease in patients by limiting spread and decreasing viral load delivered to the lungs.”
Frank, S., et al., (2020). In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2. JAMA Otolaryngology– Head & Neck Surgery.
Potential Role of Xylitol Plus Grapefruit Seed Extract Nasal Spray Solution with SARS-CoV-2: Case Series – Nov. 2020
In this case study, participants experienced a reduction of symptoms related to SARS-CoV-2 infection and received a negative test 50% faster than the average time of negativization.
Go, C. C., et al., (2020). Potential Role of Xylitol Plus Grapefruit Seed Extract Nasal Spray Solution in COVID-19: Case Series. Cureus, 12(11), e11315.
Xylitol’s Method of Action against SARS-CoV-2 – Nov. 2020
Antony Cheudjeu found that xylitol blocks receptor cites of the SARS-CoV-2 virus which inhibits it from attaching to the cell wall of its host.
Cheudjeu, A. (2020). Correlation of D-xylose with severity and morbidity-related factors of COVID-19 and possible therapeutic use of D-xylose and antibiotics for COVID-19. Life Sciences, 260, 118335.
Deactivation of SARS-CoV-2 with Xlear Nasal Spray – Nov. 2020
In this paper, researchers look at two studies performed at Utah State University (2020) and University of Geneva (2020) which showed that Xlear Nasal Spray destroyed 99.99% of the SARS-CoV-2 virus.
Ferrer, G., et al., (2020). A Nasal Spray Solution of Grapefruit Seed Extract plus Xylitol Displays Virucidal Activity Against SARS-Cov-2 In Vitro. BioRxiv.
Further Evidence of Xylitol’s Effectiveness Against SARS-CoV-2, H1N1, and Other Viruses – Jan. 2021
In this study researchers used an electron microscope to take pictures of xylitol’s and grapefruit seed extract’s (GSE) interaction with the SARS-CoV-2 virus. They concluded, “Combination therapy with GSE and xylitol may prevent spread of viral respiratory infections not just for SAR-CoV-2 but also for future H1N1 or other viral epidemics. GSE significantly reduces the viral load while xylitol prevents the virus attachment to the core protein on the cell wall.”
Cannon, M. L., et alk., (2020). In Vitro Analysis of the Anti-viral Potential of nasal spray constituents against SARS-CoV-2. BioRxiv.
Research is not considered conclusive. Always consult your healthcare provider with any questions.
